PAVmed Inc. — Operating Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/06b86ed5-2501-48aa-928b-55a59f150d3d/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-21.8M | 2025-01-01 – 2025-12-31 | evidence 0001437749-26-010115 |
| FY 2024 | $-44.5M | 2024-01-01 – 2024-12-31 | evidence 0001641172-25-000364 |
| FY 2023 | $-68.8M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-011172 |
| FY 2022 | $-91.1M | 2022-01-01 – 2022-12-31 | evidence 0001493152-24-011172 |
| FY 2021 | $-54.4M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-009202 |
| FY 2020 | $-23.4M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-006002 |
| FY 2019 | $-14.3M | 2019-01-01 – 2019-12-31 | evidence 0001493152-21-006002 |
| FY 2018 | $-10.6M | 2018-01-01 – 2018-12-31 | evidence 0001493152-19-004603 |
| FY 2017 | $-8.0M | 2017-01-01 – 2017-12-31 | evidence 0001493152-18-003367 |
| FY 2016 | $-5.7M | 2016-01-01 – 2016-12-31 | evidence 0001493152-18-003367 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).